Jardiance(Empagliflozin)<\/strong><\/a> is a medication classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. Its main application is in the treatment of type 2 diabetes. It’s useful to have some understanding of how the body regulates glucose to comprehend how Jardiance functions.<\/p>\n\n\n\nJardiance functions by blocking SGLT2, a particular protein found in the kidneys. Reabsorbing glucose from the urine back into the bloodstream is done by this protein. Jardiance lowers blood sugar levels by inhibiting the function of SGLT2, which increases the quantity of glucose expelled in the urine.<\/p>\n\n\n\n
Key mechanisms of Jardiance include:<\/strong><\/em><\/p>\n\n\n\n\n- Inhibition\/ Stopping of Glucose Reabsorption:<\/strong> SGLT2 inhibitors like Jardiance specifically target the SGLT2 protein in the kidneys. By inhibiting this protein, the medication prevents the reabsorption of glucose, allowing it to be excreted in the urine.<\/li>\n\n\n\n
- Increased Urinary Glucose Excretion:<\/strong> The inhibition of SGLT2 results in increased glucose excretion through urine. This helps to reduce the overall glucose load in the bloodstream.<\/li>\n\n\n\n
- Lowering Blood Sugar Levels:<\/strong> By reducing the reabsorption of glucose, Jardiance helps lower blood sugar levels in individuals with type 2 diabetes.<\/li>\n<\/ul>\n\n\n\n
It’s important to note that Jardiance is typically prescribed as part of a comprehensive diabetes management plan, which may include lifestyle modifications, dietary changes, and other medications. <\/strong><\/p>\n\n\n\n